Evidence map›Paper›PMID 30794467›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2019

IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment.

Deborah Rotoli, Manuel Morales, María-Del-C Maeso, Julio Ávila, Natalia D Pérez-Rodríguez, Ali Mobasheri, Cornelis J F van Noorden, Pablo Martín-Vasallo

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Role of scaffold proteins in the heterogeneity of glioblastoma.Cell communication and signaling : CCS · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Review
  8. Cell Biology Meets Cell Metabolism: Energy Production Is Similar in Stem Cells and in Cancer Stem Cells in Brain and Bone Marrow.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 6 countries.

Deborah RotoliUD of Biochemistry and Molecular Biology.
Manuel MoralesOncología Médica.
María-Del-C MaesoServicio de Anatomía Patológica.
Julio ÁvilaUD of Biochemistry and Molecular Biology.
Natalia D Pérez-RodríguezOncología Médica.
Ali MobasheriDepartment of Regenerative Medicine, State Research Institute Center for Innovative Medicine, Vilnius, Lithuania.
Cornelis J F van NoordenDepartment of Medical Biology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Pablo Martín-VasalloUD of Biochemistry and Molecular Biology.
Associazione Italiana Di Oncologia Medica · ITAcademic Medical Center · NLHospital Universitario Nuestra Señora de Candelaria · ESInstitute for Experimental Endocrinology and Oncology · ITInstituto Tecnológico de Canarias · ESState Research Institute Centre for Innovative Medicine · LTUniversidad de La Laguna · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GB) is the most frequently occurring and aggressive primary brain tumor. Glioma stem cells (GSCs) and astrocytoma cells are the predominant malignant cells occurring in GB besides a highly heterogeneous population of migrating, neovascularizing and infiltrating myeloid cells that forms a complex tumor microenvironment (TME). Cross talk between the TME cells is pivotal in the biology of this tumor and, consequently, adaptor proteins at critical junctions of signaling pathways may be crucial. Scaffold proteins (scaffolins or scaffoldins) integrate external and internal stimuli to regulate various signaling pathways, interacting simultaneously with multiple proteins involved. We investigated by double and triple immunofluorescence the localization of IQGAP1, AmotL2, and FKBP51, three closely related scaffoldins, in malignant cells and TME of human GB tumors. We found that IQGAP1 is preferentially expressed in astrocytoma cells, AmotL2 in GSCs, and FKBP51 in white blood cells in human GB tumors. As GSCs are specially the target for novel therapies, we will investigate in further studies whether AmotL2 inhibition is effective in the treatment of GB.

Indexed as

Tumor MicroenvironmentAngiomotinsCarrier ProteinsCell Line, TumorGlioblastomaHumansIntracellular Spaceras GTPase-Activating ProteinsSignal TransductionTacrolimus Binding Protein 5Tacrolimus Binding ProteinsAMOTL2 protein, humanAngiomotinsCarrier ProteinsIQ motif containing GTPase activating protein 1ras GTPase-Activating ProteinsTacrolimus Binding Protein 5Tacrolimus Binding ProteinsAmotL2astrocytoma cellsFKBP51glioblastoma microenvironmentglioma stem cellsIQGAP1pericytesscaffold proteinstumor-associated macrophages (TAMs)

Identifiers

PMID30794467
PMCPMC6598128
OpenAlexW2916231690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.